1. Home
  2. BPMC vs KEX Comparison

BPMC vs KEX Comparison

Compare BPMC & KEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • KEX
  • Stock Information
  • Founded
  • BPMC 2008
  • KEX 1921
  • Country
  • BPMC United States
  • KEX United States
  • Employees
  • BPMC N/A
  • KEX N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • KEX Marine Transportation
  • Sector
  • BPMC Health Care
  • KEX Consumer Discretionary
  • Exchange
  • BPMC Nasdaq
  • KEX Nasdaq
  • Market Cap
  • BPMC 5.8B
  • KEX 5.8B
  • IPO Year
  • BPMC 2015
  • KEX N/A
  • Fundamental
  • Price
  • BPMC $85.94
  • KEX $101.60
  • Analyst Decision
  • BPMC Buy
  • KEX Strong Buy
  • Analyst Count
  • BPMC 22
  • KEX 4
  • Target Price
  • BPMC $124.29
  • KEX $124.75
  • AVG Volume (30 Days)
  • BPMC 982.6K
  • KEX 556.2K
  • Earning Date
  • BPMC 05-01-2025
  • KEX 04-24-2025
  • Dividend Yield
  • BPMC N/A
  • KEX N/A
  • EPS Growth
  • BPMC N/A
  • KEX 32.06
  • EPS
  • BPMC N/A
  • KEX 4.91
  • Revenue
  • BPMC $508,824,000.00
  • KEX $3,265,876,000.00
  • Revenue This Year
  • BPMC $45.43
  • KEX $6.10
  • Revenue Next Year
  • BPMC $32.80
  • KEX $5.57
  • P/E Ratio
  • BPMC N/A
  • KEX $20.63
  • Revenue Growth
  • BPMC 104.04
  • KEX 5.64
  • 52 Week Low
  • BPMC $80.68
  • KEX $93.63
  • 52 Week High
  • BPMC $121.90
  • KEX $132.21
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 38.77
  • KEX 49.66
  • Support Level
  • BPMC $86.99
  • KEX $97.87
  • Resistance Level
  • BPMC $93.04
  • KEX $106.04
  • Average True Range (ATR)
  • BPMC 3.37
  • KEX 2.51
  • MACD
  • BPMC 0.07
  • KEX 0.47
  • Stochastic Oscillator
  • BPMC 12.12
  • KEX 57.51

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About KEX Kirby Corporation

Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's revenue is generated from the Marine Transportation segment.

Share on Social Networks: